文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

CD8+ T细胞亚群表型对ICU脓毒症患者的预后价值及潜在机制

Prognostic Value and Potential Mechanism of CD8+ T Subsets Phenotype in ICU Patients with Sepsis.
PubMed 文献 · Shock · 2025-10-21
一句话结论基于CD8+CD28+、CD8+CD38+、CD8+DR+比例的K-means聚类可将ICU脓毒症患者分为28天死亡率显著不同的两组,动态监测CD8+CD28+持续下降且CD8+CD38+持续升高者28天死亡率达50%。

该研究纳入220例ICU脓毒症患者(2023年8月至2024年5月),基于CD8+CD28+/CD8+%、CD8+CD38+/CD8+%、CD8+DR+/CD8+%进行K-means聚类分为两组,比较28天死亡率。组2(n=146)28天死亡率显著高于组1(n=74)(32.3% vs 17.6%,P<0.001)。动态趋势分析显示CD8+CD28+/CD8+%持续下降且CD8+CD38+/CD8+%持续升高的患者预后最差,28天死亡率为50%。联合检测CD8+CD28+/CD8+%与CD8+CD38+/CD8+%的预后价值(AUC=0.676)优于单一指标。Olink蛋白组学分析提示IL-12Rβ1是与CD8+ T细胞功能及活化亚群密切相关的关键分子介质。

要点

  • 基于CD8+CD28+/CD8+%、CD8+CD38+/CD8+%、CD8+DR+/CD8+%的K-means聚类将220例ICU脓毒症患者分为组1(n=74)与组2(n=146),组2的28天死亡率显著更高(32.3% vs 17.6%,P<0.001)。
  • 动态趋势分析显示CD8+CD28+/CD8+%持续下降且CD8+CD38+/CD8+%持续升高的患者28天死亡率为50%,为预后最差表型。
  • 联合检测CD8+CD28+/CD8+%与CD8+CD38+/CD8+%的预后AUC为0.676,优于单一指标检测。
  • Olink蛋白组学分析提示IL-12Rβ1是与CD8+ T细胞功能及活化亚群密切相关的关键分子介质。

适用人群与场景

  • 2023年8月至2024年5月纳入的220例ICU脓毒症患者。

研究设计与关键结果

  • 研究纳入220例ICU脓毒症患者,基于CD8+CD28+/CD8+%、CD8+CD38+/CD8+%、CD8+DR+/CD8+%进行K-means聚类分析分为两组。
  • 组1(n=74)与组2(n=146)比较,组2的28天死亡率显著高于组1(32.3% vs 17.6%,P<0.001)。
  • 动态趋势分析显示CD8+CD28+/CD8+%持续下降且CD8+CD38+/CD8+%持续升高的患者预后最差,28天死亡率为50%。
  • 联合检测CD8+CD28+/CD8+%与CD8+CD38+/CD8+%的预后AUC为0.676,优于单一指标检测。
  • 每组各选15例患者进行Olink蛋白组学分析,鉴定出IL-12Rβ1为与CD8+ T细胞功能及活化亚群密切相关的关键分子介质。

证据类型、等级与局限

  • 证据类型:研究论文(临床队列研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为CD8+ T细胞亚群表型可作为脓毒症的重要预后指标。
  • 作者认为IL-12Rβ1可能是影响CD8+ T细胞功能的关键分子,为脓毒症监测和免疫治疗提供了新的潜在靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: While CD8+ T-cell subsets play a crucial role in sepsis prognosis, the prognostic value of their dynamic changes and molecular mechanisms remains incompletely understood. Compared to static single-timepoint measurements, the prognostic role of repeated measurements over time remains undetermined.

METHODS: The study included 220 intensive care unit patients with sepsis (2023.08-2024.05). K-means clustering analysis based on CD8+CD28+/CD8+%, CD8+CD38+/CD8+%, and CD8+DR+/CD8+% was used to categorize patients into two groups. Clinical data were collected and analyzed for 28-day mortality prediction. Fifteen patients from each group were selected for Olink proteomics analysis to investigate differentially expressed proteins and conduct functional enrichment analysis.

RESULTS: Using K-means clustering analysis based on CD8+ T-cell subset phenotypes, patients were divided into group 1 (n = 74) and group 2 (n = 146), with group 2 demonstrating significantly higher 28-day mortality compared to group 1 (32.3% vs. 17.6%, P < 0.001). Further dynamic trend analysis revealed that patients exhibiting continuously decreasing CD8+CD28+/CD8+% and increasing CD8+CD38+/CD8+% had the poorest prognosis, with a 28-day mortality rate of 50%. The combined measurement of CD8+CD28+/CD8+% and CD8+CD38+/CD8+% showed enhanced prognostic value (area under the curve = 0.676) compared to individual measurements, indicating the importance of monitoring multiple T-cell subset markers. Additionally, Olink proteomic analysis identified IL-12Rβ1 as a key molecular mediator closely associated with CD8+ T-cell function and activation subsets, providing insights into the underlying mechanism of immune dysfunction in sepsis patients.

CONCLUSIONS: CD8+ T-cell subset phenotypes serve as important prognostic indicators in sepsis, with IL-12Rβ1 potentially being a key molecule affecting CD8+ T-cell function, providing a new potential target for sepsis monitoring and immunotherapy.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Zhao G, Wang H, Zhang J, et al. Prognostic Value and Potential Mechanism of CD8+ T Subsets Phenotype in ICU Patients with Sepsis. Shock. 2025. PMID: 41615731. doi:10.1097/SHK.0000000000002730

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。